AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06644950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Efficacy and safety of administering 1 or two cartridges of anesthesia
Description: The investigator will administer the first anesthesia for NDI block with a cartridge of 4% articaine anesthetic at 1:100,000 . At the end, an envelope containing the assignment to the experimental or control group will be opened.~In the control group, only the first anesthetic (1.8 mL of articaine 4% 1:100,000) will be injected and a second puncture will be simulated, contacting the syringe without the needle, in the same area, counting up to 30 seconds.~In the experimental group two anesthetic cartridges of articaine 4% 1:100,000 will be administered with the direct technique for the inferior alveolar nerve block.
Study NCT06644950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Efficacy and safety of administering 1 or two cartridges of anesthesia
Description: The investigator will administer the first anesthesia for NDI block with a cartridge of 4% articaine anesthetic at 1:100,000 . At the end, an envelope containing the assignment to the experimental or control group will be opened.~In the control group, only the first anesthetic (1.8 mL of articaine 4% 1:100,000) will be injected and a second puncture will be simulated, contacting the syringe without the needle, in the same area, counting up to 30 seconds.~In the experimental group two anesthetic cartridges of articaine 4% 1:100,000 will be administered with the direct technique for the inferior alveolar nerve block.
Study NCT06644027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jefcare Sterile Medical Sheets
Description: Screening period (day 0): normal routine medical sheet and skin care regimen. Intervention days 1, 2, 3, 4, 5: Jefcare Sterile Medical Sheets and skin care regimen.
Study NCT06644027 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Molicare Premium Bed Mat
Description: Screening period (day 0): normal routine medical sheet and skin care regimen. Intervention days 1, 2, 3, 4, 5: MoliCare Premium Bed Mats and skin care regimen.
Study NCT05516472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microbial Transplant Therapy
Description: Participants will take microbial capsules, 2 capsules daily for 7 days
Study NCT05516472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will take placebo capsules
Study NCT04948073 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic neuromuscular stabilization approach
Description: The experimental group will follow a DNS exercise protocol based on previous procedure for a whole period of 6 weeks (three 50-min sessions per week) in addition the conventional treatment.
Study NCT04948073 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Patients from both groups will receive a conventional 6-week treatment programme (18 treatment sessions, three a week, for 30-40min duration).
Study NCT05981456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: patient safety competency
Description: Investigation of the effect of patient safety education given with the flipped education model and traditional education model on the competence levels of the students.
Study NCT05981456 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: patient safety competency
Description: Investigation of the effect of patient safety education given with the flipped education model and traditional education model on the competence levels of the students.
Study NCT05981456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: satisfaction with the training method
Description: Investigation of the effect of patient safety education given with the flipped education model and traditional education model on the satisfaction levels of the students from the education methods.
Study NCT05981456 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: satisfaction with the training method
Description: Investigation of the effect of patient safety education given with the flipped education model and traditional education model on the satisfaction levels of the students from the education methods.
Study NCT06329869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan
Description: Sacituzumab govitecan, 10 mg/kg intravenous infusion (the first infusion is to be administered over 3 hours; subsequent infusions may be administered over 1 to 2 hours if previous infusions were well tolerated) on day 1 and 8 of 21-day cycle.
Study NCT05523297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Octaplex
Description: Prothrombin complex concentrate
Study NCT05523297 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Frozen Plasma Product, Human
Description: If additional treatment is required after the maximum dose of IMP is administered or the treatment period has elapsed, patients in both groups will receive frozen plasma
Study NCT06279520 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: VR Driving Simulator
Description: Evaluation of usual road driving abilities and assessment of response capabilities in accident-prone situations through a VR driving simulator
Study NCT06279520 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Computerized Neurocognitive Function Test
Description: Evaluation of cognitive levels including attention and memory (the Trail Making Test, Digit Span Test, Auditory (or Visual) Continuous Performance Test , and Card Sorting)
Study NCT06279520 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Driver Test Station
Description: Conducting qualified tests of a person's basic physical driving ability including steering, acceleration and braking, using Driver Test Station(Autoadapt AB, Stenkullen, Sweden)
Study NCT06279520 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: On-road field driving Test
Description: Researchers and driver's license supervisors ride in the driver's license test vehicle to evaluate the subject's actual driving ability. the validity of the VR simulator by comparing the results of the VR simulator with the actual vehicle driving ability.
Study NCT05391802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair
Description: Transcatheter mitral valve repair (TMVr) is a minimally invasive procedure. Doctors place a thin tube (calleda catheter) into a large vein to reach your heart. A clip is then placed onto the center of your mitral valve. The valve continues to open and close, allowing blood to flow through while reducing MR.
Study NCT05420532 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exergaming
Description: A video game-based physical activity training applied using a commercial game console.
Study NCT04671628 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxing music
Description: Participants will be asked to listen to relaxing music for 30 minutes each day. They will allowed to choose between several playlists based on their preference.
Study NCT05285657 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Two-step malaria RDT detecting PfHRP2/pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard Diagnostics, Hagal-Dong, Korea)
Description: The interpretation of the two-step malaria RDT will be done as follow:~* PfHRP2(+)/pLDH(+): falciparum malaria or co-infection with non-falciparum malaria;~* PfHRP2(-)/pLDH(+): non-falciparum malaria or falciparum malaria with deletion of hrp2;~* PfHRP2(-)/pLDH(-): negative results~* PfHRP2(+)/pLDH(-): inconclusive results and information on previous antimalarial treatment is needed to differentiate:~Within the past 28 days:~* If previous antimalarial treatment is reported, the malaria diagnosis is reported as negative result. Nonetheless, the antimalarial treatment decision will be based on malaria microscopy;~* If previous antimalarial treatment is not reported, the malaria diagnosis is reported as positive result.~Other PoC tests for bacterial infections The two-step malaria RDT will be supported by PoC test listed above to diagnose bacterial or viral infection in all patients.
Study NCT05598931 — intervention group
Intervention type: DEVICE
Intervention: Transcranial Magnetic Stimulation
Description: Subjects will participate in an on-line neuro-navigation session in which 6 TMS coil positions will be recorded.
Study NCT05326750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gamma tACS (40 Hz) over the superior parietal cortex
Description: Single session of gamma tACS (40 Hz) over the superior parietal cortex
Study NCT05326750 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Gamma tACS (40 Hz) over the superior parietal cortex
Description: Single session of gamma tACS (40 Hz) over the superior parietal cortex
Study NCT06096350 — intervention group
Intervention type: DEVICE
Intervention: indirect calorimetry analysis
Description: indirect calorimetry analysis with K5 (COSMED, Italy) during six minute walk test or timed up and go test.
Study NCT06074458 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Glucosano
Description: Glucosano is a remote patient monitoring diabetes dashboard with a patient facing Smartphone application
Study NCT06074458 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Community Health Worker diabetes technology coach
Description: Community Health Workers will work with participants as a diabetes technology coach during scheduled and as needed visits
Study NCT04866329 — intervention group
Intervention type: OTHER
Intervention: Blood sample
Description: Additional blood sampling at the end of ovarian stimulation monitoring (the eve of the oocyte pick-up)
Study NCT04866329 — intervention group
Intervention type: OTHER
Intervention: Urine sample
Description: Collection of the first urine in the morning on the day of the oocyte pick-up
Study NCT04866329 — intervention group
Intervention type: OTHER
Intervention: Follicular fluid and granulosa cells sample
Description: Collection of follicular fluid and granulosa cells during oocyte pick-up.
Study NCT05388396 — intervention group
Intervention type: OTHER
Intervention: PIMS-TS diagnostic a treatment
Description: PIMS-TS diagnostic a treatment
Study NCT06365541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: oral Dapagliflozin tablets 10mg/day for 6 months
Study NCT06608355 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Human Dopaminergic Progenitor Cells
Description: Single injection of Human Dopaminergic Progenitor Cells into the putamen of brain.
Study NCT04771247 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardia Band Ligation
Description: Patients will undergo cardia band ligation at the level of the GEJ.
Study NCT06676618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal Exercise Training
Description: The exercise training consisting of aerobic, strengthening and balance exercises will be applied for 12 weeks/3days for 1hour. One day of the exercise training will be performed in a clinical environment with a physiotherapist, and the other 2 days of the week, participants will be asked to apply asynchronous video-based telerehabilitation over the internet in their own homes. The asynchronous video-based telerehabilitation application will be performed through an account created specifically for the participant on the www.telenororehab.com website. The exercise program will be created according to the individual's condition and progression will be provided every 3 weeks. Patients who do not attend 3 consecutive sessions will be excluded from the study.
Study NCT06676618 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants in the control group will be placed on the waiting list after all evaluation methods have been applied and will be re-evaluated at the end of 12 weeks. After the evaluations, individuals in the control group will also be given multimodal exercise training.
Study NCT06616519 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BenQ Materials MSENCI soft hydrophilic contact lenses
Description: Test lenses were to be worn for approximately 90 days.
Study NCT06616519 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Visco Oxypure Color soft hydrophilic contact lenses
Description: Control lenses were to be worn for approximately 90 days
Study NCT06678425 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral magnetic stimulator
Description: a non-invasive method of delivering a rapidly pulsed, high-intensity magnetic field to peripheral muscles
Study NCT06678425 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Peripheral magnetic stimulator
Description: The same coil as real rPMS, but in a position perpendicular to the skin
Study NCT06678399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KELI-101
Description: KELI-101 consists of ex vivo expanded placental mesenchymal stromal cells (PMSCs) in a 10% cryopreservation solution.
Study NCT06678399 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (placebo)
Description: Plasmalyte
Study NCT06678308 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Embolisation with Magic Glue®
Description: Magic Glue® will be injected within prostatic arteries, leading to ischaemia and necrosis of part of the adenomatous tissue of the prostate gland
Study NCT06678308 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Embolisation with Embosphere®
Description: Embosphere® will be injected within prostatic arteries, leading to ischaemia and necrosis of part of the adenomatous tissue of the prostate gland
Study NCT06392802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rehabilitation treatment using Muvity
Description: The users have the support of the telerehabilitation system Muvity
Study NCT06413927 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online Vehicle and Driver Safety Training
Description: This online video education program provides education in vehicle and driver safety (e.g. vehicle maintenance, adjusting car seats and seatbelts). This online training will take up to 2 hours to complete and will have a short quiz at the end to determine compliance with this online training.
Study NCT06413927 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Driver Skills Training
Description: The online driver training is the Accelerated Curriculum to Create Effective Learning (ACCEL) is designed to enhance the ability to anticipate, recognize and respond to hazards and to maintain attention to the road. The training is delivered online via a computer and can be done from home or at a school or other site that has a computer with internet access. It requires up to two hours to complete, and will be hosted on a platform that will track progress and completion through the training (such as accuracy, duration in modules, time to complete) and a short quiz will be provided at the end to assess learning.
Study NCT06413927 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behind-the-Wheel Driver Training
Description: The professional behind-the-wheel training course will be conducted in-person, delivered by local driving school partner Driver Training Services. The curriculum consists of 6 hours of training with assigned practice between lessons, and meets Pennsylvania and national standards. Post-lesson forms completed by the instructors will record adherence and consistency (intervention fidelity).
Study NCT05753618 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granulocyte Colony-Stimulating Factor (G-CSF)
Description: Participants will receive G-CSF injection (either filgrastim or pegfilgrastim) after each paclitaxel cycle of DD-AC/T chemotherapy.
Study NCT05753618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
Description: Participants will omit the use of G-CSF (either filgrastim or pegfilgrastim) after each paclitaxel cycle of DD-AC/T chemotherapy
Study NCT04705025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy
Description: Undergo CBSM using the BNT001 app
Study NCT05833334 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Public health infographic (AIM 3)
Description: Standard public health infographic about home air radon testing, plus information about requesting a free home air radon test kit
Study NCT05833334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online health promotion intervention tailored by smoking status (AIM 3)
Description: Online health promotion intervention with messaging about home air radon testing tailored by the participant's stated smoking status, plus information about requesting a free home air radon test kit
Study NCT05833334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3)
Description: Online health promotion intervention with messaging about home air radon testing tailored by the participant's stated smoking status, plus information about requesting a free home air radon test kit, plus reminder messages about home air radon testing sent over two months
Study NCT05833334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Focus group with educational overview (AIM 1)
Description: 90-minute online focus group discussion about home air radon testing, plus an educational overview about home air radon testing using a standard public health infographic
Study NCT05678582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Liver biopsy
Description: liver biopsy were taken then evaluated by histopathological examination
Study NCT04834674 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: DEB-TACE combined with apatinib and PD-1 antibody
Description: combination of local therapy (DEB-TACE), antiangiogenic therapy (apatinib), and immunotherapy (PD-1 antibody)
Study NCT04939207 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT-FFR
Description: CT-images will be processed by an algorithm to calculate FFR-values of the full coronary tree
Study NCT04939207 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Angiography-derived FFR
Description: FFR-values are calculated during coronary angiography based on the acquired images of the coronary arteries
Study NCT04939207 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Angiography with invasive FFR-measurements
Description: during coronary angiography, a specialized pressure wire is passed through the coronary stenosis to calculate FFR based on the difference between the actual pressure and the expected pressure in the hypothetical healthy coronary artery.
Study NCT05452941 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic test on urine samples
Description: Testing by BinaxNOW® S. pneumoniae and serotype-specific urine antigen detection (UAD) assays (UAD-1 and UAD-2).
Study NCT05820074 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neural Activity Recording
Description: Neural Activity is measured using EEG in all groups. Additionally, in Parkinson's patients, local-field-potentials from deep brain stimulation electrodes are recorded.
Study NCT05820074 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Movement Parameter Recording
Description: Gait-related movement parameters are non-invasively recorded using motion capture, accelerometers and electromyography.
Study NCT05820074 — intervention group
Intervention type: OTHER
Intervention: Neuromodulation
Description: Neural signals are recorded with the electrodes of the deep brain stimulation device. Parkinson's patients are asked to modulate their neural activity by observing the streamed neural activity and applying mental strategies.
Study NCT06224595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS32582 capsule
Description: Participants receive CS32582 orally single or multiple doses
Study NCT06224595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Participants receive placebo matching CS32582 orally single or multiple doses
Study NCT05835466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: reparixin
Description: reparixin at 1200mg TID three times per day.
Study NCT06068738 — intervention group
Intervention type: OTHER
Intervention: Biological sample collection
Description: Collection of ascites, blood and fresh tumour tissues (if available)
Study NCT06555081 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib IR
Description: Tablet
Study NCT06555081 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib XR
Description: Tablet
Study NCT06566300 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: injection of autologous nanofat grafting
Description: Injection of nanfat graft
Study NCT06566300 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microneedling with autologus nanofat graft
Description: delivery of nanofat graft with microneedling
Study NCT06568393 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calisthenic exercise
Description: Calisthenic exercise program was included: jumping jack, burpee, mountain climber, squat thrust, squat, squat jump, split and alternate exercises.
Study NCT06568393 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calisthenic exercise
Description: Calisthenic exercise program was included: jumping jack, burpee, mountain climber, squat thrust, squat, squat jump, split and alternate exercises.
Study NCT06151431 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alpha-Agonist
Description: The maternal systolic blood pressure was consistently maintained above 80% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.
Study NCT06529237 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: LDH-based malaria rapid diagnostic test
Description: Malaria testing using an LDH-based malaria rapid diagnostic test will be added to standard routine testing of suspected cases at health facilities